A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors
A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors
Recruiting · NCT06992713 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-06-18 | NCT06992713 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer hospital | Beijing | China | 84 |
| Jiangsu Province Hospital | Nanjing | China | 89 |
| Peking University Shougang Hospital | Beijing | China | 2 |
| Shanghai East Hospital | Shanghai | China | 33 |